PROQUAD
INJ PSU LQF 1+1X0,5ML ISP+2J III
| SÚKL code | 0026123 |
|---|---|
| Name of the product | PROQUAD |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | PROQUAD |
| Supplement | INJ PSU LQF 1+1X0,5ML ISP+2J III |
| Strenght | |
| Pharmaceutical form | Powder and solvent for suspension for injection |
| Package | 1+1X0,5ML ISP+2J III |
| Route | Subcutaneous/intramucsular use |
| Wrap type | Vial |
| Legal status | na lékařský předpis |
| Active substance |
LIVE ATTENUATED MEASLES VIRUS (VIRUS MORBILLORUM VIVUM ATTENUATUM) LIVE ATTENUATED MUMPS VIRUS (VIRUS PAROTITIDIS VIVUM ATTENUATUM) LIVE ATTENUATED RUBELLA VIRUS (VIRUS RUBELLAE VIVUM ATTENUATUM) LIVE ATTENUATED VARICELLA VIRUS (VIRUS VARICELLAE VIVUM ATTENUATUM) |
| ATC group | J07BD54 |
| ATC group name | SPALNIČKY-PŘÍUŠNICE-ZARDĚNKY-PLANÉ NEŠTOVICE, ŽIVÁ ATENUOVANÁ VAKCÍNA |
Marketing authorisation information
| Registration Number | EU/1/05/323/010 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Merck Sharp & Dohme B.V., Haarlem |
| MA Holder country | NIZOZEMSKO |
cz